Antinuclear Antibody Test Market is expected to generate a revenue of USD 4.71 Billion by 2030, Globally, at 12.05% CAGR: Verified Market Research®
The market report is a good combination of qualitative and quantitative data that highlights significant market changes, obstacles that business and the competition must overcome, as well as new possibilities and trends in the global Antinuclear Antibody Test Market.
JERSEY CITY, N.J., Jan. 31, 2023 /PRNewswire/ -- Verified Market Research® recently published a report, "Antinuclear Antibody Test Market" By Product (Reagents And Assay Kits, Systems), By Technique (Elisa, Immunofluorescence Assay), By Disease (Rheumatoid Arthritis, Systemic Lupus Erythematosus), and By Geography.
As per the deep research carried out by Verified Market Research®, the global Antinuclear Antibody Test Market size was valued at USD 1.55 Billion in 2021 and is projected to reach USD 4.71 Billion by 2030, growing at a CAGR of 12.05% from 2023 to 2030.
Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=33069
Browse in-depth TOC on "Antinuclear Antibody Test Market"
202 - Pages
126 – Tables
37 – Figures
Global Antinuclear Antibody Test Market Overview
Antinuclear Antibodies are a group of autoantibodies produced by the immune system of an individual when it fails to distinguish between self and foreign particles. The Antinuclear Antibody Test (ANA) is also known as the fluorescent antinuclear antibody (FANA) test and the Antinuclear Antibody screen. Antinuclear antibodies attack the cells of the body. As a result, these are known as antinuclear because they target the nucleus of cells. They react with healthy cells in the body, causing symptoms and signs such as tissue inflammation, muscle and joint strain, and fatigue.
The ANA test aids in the diagnosis of autoimmune conditions like lupus and rheumatoid arthritis. The global antinuclear antibody test market is expanding as a result of rising technological development, acceptance of contemporary methods, and an increase in the prevalence of various autoimmune diseases. Additionally, the market has been able to expand quickly thanks to the population's growing awareness of the signs and diagnosis of autoimmune diseases. Additionally, an increase in healthcare spending has made it possible for people to receive early diagnosis and treatment, which is expected to positively influence the growth of the global market for antinuclear antibody tests.
Verified Market Research® narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements that interests the client. The "Global Antinuclear Antibody Test Market" is mainly bifurcated into sub-segments which can provide classified data regarding the latest trends in the market.
The "Global Antinuclear Antibody Test Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Erba Diagnostics, Inc., Alere Inc., Antibodies Inc., Inova Diagnostics.
Based on the research, Verified Market Research® has segmented the global Antinuclear Antibody Test Market into Product, Technique, Disease, and Geography.
- Antinuclear Antibody Test Market, by Product
- Reagents & Assay Kits
- Software & Services
- Antinuclear Antibody Test Market, by Technique
- Immunofluorescence Assay
- Multiplex Assay
- Antinuclear Antibody Test Market, by Disease
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
- Sjögren's Syndrome
- Antinuclear Antibody Test Market, by Geography
- North America
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- Middle East & Africa
- Latin America
Browse Related Reports:
Antibody Market By Product Type (Monoclonal antibodies, Polyclonal antibodies), By Disease Indication (cardiovascular diseases, CNS disorders, cancer), By End User (hospitals, diagnostic laboratories), By Geography, And Forecast
Bispecific Antibody Therapeutics Market By Indication (oncology, autoimmune disease), By End-Users (hospitals, specialty clinics, home care), By Geography, And Forecast
Antibody Production Market By Product Type (Polyclonal Antibody, Monoclonal Antibody, Murine), By End-User (Pharmaceutical and Biotechnology Companies, Diagnostic Laboratories), By Geography, And Forecast
Autoantibody Kit Market By Product (Indirect Immunofluorescence (IIF), Immunodiffusion, Immunoblotting, ELISA, Others), By Application (Hospitals and Clinics, Clinical Laboratories, Others), By Geography, And Forecast
Top 10 Antibody Reagent Companies detecting reagents for protecting patients
Visualize Antinuclear Antibody Test Market using Verified Market Intelligence -:
Verified Market Intelligence is our BI Enabled Platform for narrative storytelling in this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue-impacting decisions for a brilliant future.
VMI provides a holistic overview and global competitive landscape with respect to Region, Country, Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.
Verified Market Research® is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research® provides advanced analytical research solutions while offering information-enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.
We study 14+ categories from Semiconductors & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & Construction, Agriculture industry and Medical Devices from over 100 countries.
Mr. Edwyne Fernandes
Verified Market Research®
US: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: +1 (800)-782-1768
Follow Us: LinkedIn | Twitter
View original content:https://www.prnewswire.com/news-releases/antinuclear-antibody-test-market-is-expected-to-generate-a-revenue-of-usd-4-71-billion-by-2030--globally-at-12-05-cagr-verified-market-research-301734678.html
SOURCE Verified Market Research
Upcoming Life Sciences Events
- March 2023
- Zurich: Swiss Nordic Bio 2023
- April 2023
- Basel: Swiss Biotech Day 2023
- Brussels: Cell and Gene Therapy Summit
Latest company news
Freeline Therapeutics to Host Full Year 2022 Financial Results Call
Vaccitech Announces Positive Topline Final Data for HBV002 Study in People with Chronic Hepatitis B
Asia Pacific Mammography Devices Market Analysis Report 2022: Focus on China, India, Japan, South Korea, Australia, New Zealand, Malaysia, Vietnam, Indonesia, & Singapore